We believe that NADH supplementation may impact inflammation and associated lung injury by preventing CSE-induced mitochondrial dysfunction reported as an important source of ROS and proinflammatory factors in COPD, such as TNFα/IL-1β, which led to the recruitment of neutrophils [51]. Here, IL1B is linked to chronic obstructive pulmonary disease.